{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:15:45Z","timestamp":1793927745126,"version":"4.8.0"},"reference-count":155,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MSIDS Research Foundation (MRF)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Lyme disease and associated co-infections are increasing worldwide and approximately 20% of individuals develop chronic Lyme disease (CLD)\/Post-Treatment Lyme Disease Syndrome (PTLDS) despite early antibiotics. A seven- to eight-week protocol of double dose dapsone combination therapy (DDDCT) for CLD\/PTLDS results in symptom remission in approximately 50% of patients for one year or longer, with published culture studies indicating higher doses of dapsone demonstrate efficacy against resistant biofilm forms of Borrelia burgdorferi. The purpose of this study was, therefore, to evaluate higher doses of dapsone in the treatment of resistant CLD\/PTLDS and associated co-infections. A total of 25 patients with a history of Lyme and associated co-infections, most of whom had ongoing symptoms despite several courses of DDDCT, took one or more courses of high dose pulsed dapsone combination therapy (200 mg dapsone \u00d7 3\u20134 days and\/or 200 mg BID \u00d7 4 days), depending on persistent symptoms. The majority of patients noticed sustained improvement in eight major Lyme symptoms, including fatigue, pain, headaches, neuropathy, insomnia, cognition, and sweating, where dapsone dosage, not just the treatment length, positively affected outcomes. High dose pulsed dapsone combination therapy may represent a novel therapeutic approach for the treatment of resistant CLD\/PTLDS, and should be confirmed in randomized, controlled clinical trials.<\/jats:p>","DOI":"10.3390\/antibiotics11070912","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T07:51:56Z","timestamp":1657180316000},"page":"912","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease\/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4952-883X","authenticated-orcid":false,"given":"Richard I.","family":"Horowitz","sequence":"first","affiliation":[{"name":"Hudson Valley Healing Arts Center, Hyde Park, NY 12538, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0482-8660","authenticated-orcid":false,"given":"Phyllis R.","family":"Freeman","sequence":"additional","affiliation":[{"name":"Hudson Valley Healing Arts Center, Hyde Park, NY 12538, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cll.2015.08.003","article-title":"Ecology and Epidemiology of Lyme Borreliosis","volume":"35","author":"Schotthoefer","year":"2015","journal-title":"Clin. Lab. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3201\/eid2702.202731","article-title":"Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010\u20132018","volume":"27","author":"Kugeler","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3201\/eid2708.204763","article-title":"Comparison of Lyme Disease in the United States and Europe","volume":"27","author":"Marques","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"DeLong, A., Hsu, M., and Kotsoris, H. (2019). Estimation of Cumulative Number of Post-Treatment Lyme Disease Cases in the US, 2016 and 2020. BMC Public Health, 19.","DOI":"10.1186\/s12889-019-6681-9"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.idc.2015.02.012","article-title":"Posttreatment Lyme Disease Syndrome","volume":"29","author":"Aucott","year":"2015","journal-title":"Infect. Dis. Clin. North Am."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Petrulionien\u0117, A., Radzi\u0161auskien\u0117, D., Ambrozaitis, A., \u010caplinskas, S., Paulauskas, A., and Venalis, A. (2020). Epidemiology of Lyme Disease in a Highly Endemic European Zone. Medicina, 56.","DOI":"10.3390\/medicina56030115"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Adrion, E.R., Aucott, J., Lemke, K.W., and Weiner, J.P. (2015). Health Care Costs, Utilization and Patterns of Care Following Lyme Disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116767"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Mac, S., da Silva, S.R., and Sander, B. (2019). The Economic Burden of Lyme Disease and the Cost-Effectiveness of Lyme Disease Interventions: A Scoping Review. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210280"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI21681","article-title":"The Emergence of Lyme Disease","volume":"113","author":"Steere","year":"2004","journal-title":"J. Clin. Invest."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12016-021-08906-w","article-title":"A Review of Post-Treatment Lyme Disease Syndrome and Chronic Lyme Disease for the Practicing Immunologist","volume":"62","author":"Wong","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Vrijmoeth, H.D., Ursinus, J., Harms, M.G., Zomer, T.P., Gauw, S.A., Tulen, A.D., Kremer, K., Sprong, H., Knoop, H., and Vermeeren, Y.M. (2019). Prevalence and Determinants of Persistent Symptoms after Treatment for Lyme Borreliosis: Study Protocol for an Observational, Prospective Cohort Study (LymeProspect). BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-3949-8"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/IJGM.S44114","article-title":"Review of Evidence for Immune Evasion and Persistent Infection in Lyme Disease","volume":"6","author":"Berndtson","year":"2013","journal-title":"Int. J. Gen. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF01409985","article-title":"Intracellular Persistence of Borrelia burgdorferi in Human Synovial Cells","volume":"16","author":"Girschick","year":"1996","journal-title":"Rheumatol. Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/art.1780361118","article-title":"Persistence of Borrelia burgdorferi in Ligamentous Tissue from a Patient with Chronic Lyme Borreliosis","volume":"36","author":"Hahn","year":"1993","journal-title":"Arthritis Rheum."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Embers, M.E., Barthold, S.W., Borda, J.T., Bowers, L., Doyle, L., Hodzic, E., Jacobs, M.B., Hasenkampf, N.R., Martin, D.S., and Narasimhan, S. (2012). Persistence of Borrelia burgdorferi in Rhesus Macaques Following Antibiotic Treatment of Disseminated Infection. PLoS ONE, 7.","DOI":"10.1371\/annotation\/4cafed66-fb84-4589-a001-131d9c50aea6"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"13498","DOI":"10.1073\/pnas.1904170116","article-title":"Borrelia burgdorferi Peptidoglycan Is a Persistent Antigen in Patients with Lyme Arthritis","volume":"116","author":"Jutras","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.1996.03530450047031","article-title":"Concurrent Lyme Disease and Babesiosis. Evidence for Increased Severity and Duration of Illness","volume":"275","author":"Krause","year":"1996","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Horowitz, R.I., and Freeman, P.R. (2019, March 10). Precision Medicine: Retrospective Chart Review and Data Analysis of 200 Patients on Dapsone Combination Therapy for Chronic Lyme Disease\/Post-Treatment Lyme Disease Syndrome: Part 1. Available online: https:\/\/www.dovepress.com\/precision-medicine-retrospective-chart-review-and-data-analysis-of-200-peer-reviewed-article-IJGM.","DOI":"10.2147\/IJGM.S193608"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3389\/fmed.2021.666554","article-title":"Recent Progress in Lyme Disease and Remaining Challenges","volume":"8","author":"Bobe","year":"2021","journal-title":"Front. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Horowitz, R.I., and Freeman, P.R. (2018). Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease\/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2. Healthcare, 6.","DOI":"10.3390\/healthcare6040129"},{"key":"ref_21","unstructured":"Horowitz, R. (2013). Why Can\u2019t I Get Better? Solving the Mystery of Lyme and Chronic Disease, St. Martin\u2019s Press. [1st ed.]."},{"key":"ref_22","unstructured":"Horowitz, R. (2017). How Can I Get Better?: An Action Plan for Treating Resistant Lyme & Chronic Disease, St. Martin\u2019s Griffin. [1st ed.]."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Feng, J., Auwaerter, P.G., and Zhang, Y. (2015). Drug Combinations against Borrelia burgdorferi Persisters In Vitro: Eradication Achieved by Using Daptomycin, Cefoperazone and Doxycycline. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117207"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Sapi, E., Bastian, S.L., Mpoy, C.M., Scott, S., Rattelle, A., Pabbati, N., Poruri, A., Burugu, D., Theophilus, P.A.S., and Pham, T.V. (2012). Characterization of Biofilm Formation by Borrelia burgdorferi in Vitro. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048277"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Feng, J., Zhang, S., Shi, W., and Zhang, Y. (2017). Activity of Sulfa Drugs and Their Combinations against Stationary Phase B. Burgdorferi In Vitro. Antibiotics, 6.","DOI":"10.1101\/112607"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1038\/emi.2015.56","article-title":"Persister Mechanisms in Borrelia burgdorferi: Implications for Improved Intervention","volume":"4","author":"Feng","year":"2015","journal-title":"Emerg. Microbes Infect."},{"key":"ref_27","first-page":"125","article-title":"Stationary Phase Persister\/Biofilm Microcolony of Borrelia burgdorferi Causes More Severe Disease in a Mouse Model of Lyme Arthritis: Implications for Understanding Persistence, Post-Treatment Lyme Disease Syndrome (PTLDS), and Treatment Failure","volume":"27","author":"Feng","year":"2019","journal-title":"Discov. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1128\/JB.01187-12","article-title":"Regulating Antibiotic Tolerance within Biofilm Microcolonies","volume":"194","author":"Mah","year":"2012","journal-title":"J. Bacteriol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"fnv120","DOI":"10.1093\/femsle\/fnv120","article-title":"Biofilm Formation by Borrelia burgdorferi Sensu Lato","volume":"362","author":"Timmaraju","year":"2015","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4172\/2155-9554.1000345","article-title":"The Use of Dapsone as a Novel \u201cPersister\u201d Drug in the Treatment of Chronic Lyme Disease\/Post Treatment Lyme Disease Syndrome","volume":"7","author":"Horowitz","year":"2016","journal-title":"J. Clin. Exp. Dermatol. Res."},{"key":"ref_31","unstructured":"Fearnley, A., Gupta, K., Freeman, P.R., and Horowitz, R.I. (2016, January 4). Effect of Dapsone and Its Antimicrobial Combinations on Borrelia burgdorferi Biofilms. Proceedings of the ILADS 16th Annual Meeting, Boston, MA, USA."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Liegner, K.B. (2019). Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases. Antibiotics, 8.","DOI":"10.3390\/antibiotics8020072"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Gao, J., Gong, Z., Montesano, D., Glazer, E., and Liegner, K. (2020). \u201cRepurposing\u201d Disulfiram in the Treatment of Lyme Disease and Babesiosis: Retrospective Review of First 3 Years\u2019 Experience in One Medical Practice. Antibiotics, 9.","DOI":"10.3390\/antibiotics9120868"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Horowitz, R.I., Murali, K., Gaur, G., Freeman, P.R., and Sapi, E. (2020). Effect of Dapsone Alone and in Combination with Intracellular Antibiotics against the Biofilm Form of B. Burgdorferi. BMC Res. Notes, 13.","DOI":"10.1186\/s13104-020-05298-6"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fmed.2017.00169","article-title":"Selective Essential Oils from Spice or Culinary Herbs Have High Activity against Stationary Phase and Biofilm Borrelia burgdorferi","volume":"4","author":"Feng","year":"2017","journal-title":"Front. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Feng, J., Shi, W., Miklossy, J., Tauxe, G.M., McMeniman, C.J., and Zhang, Y. (2018). Identification of Essential Oils with Strong Activity against Stationary Phase Borrelia burgdorferi. Antibiotics, 7.","DOI":"10.1101\/260091"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1556\/1886.2015.00031","article-title":"Effectiveness of Stevia Rebaudiana Whole Leaf Extract Against the Various Morphological Forms of Borrelia burgdorferi in Vitro","volume":"5","author":"Theophilus","year":"2015","journal-title":"Eur. J. Microbiol. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/GMO.1000153","article-title":"Effective Killing of Borrelia burgdorferi in Vitro with Novel Herbal Compounds","volume":"2","author":"Karvonen","year":"2018","journal-title":"Gen. Med. Open"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Horowitz, R., and Freeman, P.R. (2020). Efficacy of Double-Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease\/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Retrospective Chart Review. Antibiotics, 9.","DOI":"10.20944\/preprints202009.0009.v1"},{"key":"ref_40","unstructured":"Kurien, G., Jamil, R.T., and Preuss, C.V. (2022). Dapsone. StatPearls, StatPearls Publishing."},{"key":"ref_41","unstructured":"Ludlow, J.T., Wilkerson, R.G., and Nappe, T.M. (2022). Methemoglobinemia. StatPearls, StatPearls Publishing."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1526-4637.2012.01383.x","article-title":"Methemoglobinemia in the Setting of Chronic Transdermal Lidocaine Patch Use","volume":"13","author":"Weingarten","year":"2012","journal-title":"Pain Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/03630268808998035","article-title":"The Reduction of Methemoglobin Levels by Antioxidants","volume":"12","author":"Stratton","year":"1988","journal-title":"Hemoglobin"},{"key":"ref_44","unstructured":"Gristan, Y.D., and Moosavi, L. (2022). Folinic Acid. StatPearls, StatPearls Publishing."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1572-0241.2006.00465.x","article-title":"Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium Difficile Disease","volume":"101","author":"McFarland","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/IAI.67.1.302-307.1999","article-title":"Saccharomyces Boulardii Protease Inhibits the Effects of Clostridium Difficile Toxins A and B in Human Colonic Mucosa","volume":"67","author":"Castagliuolo","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/0269881109359098","article-title":"CNS Toxicity Involving Methylene Blue: The Exemplar for Understanding and Predicting Drug Interactions That Precipitate Serotonin Toxicity","volume":"25","author":"Gillman","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"ref_48","unstructured":"Sub Laban, T., and Saadabadi, A. (2022). Monoamine Oxidase Inhibitors (MAOI). StatPearls, StatPearls Publishing."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13256-016-0865-z","article-title":"Disulfiram Neuropathy: Two Case Reports","volume":"10","author":"Tran","year":"2016","journal-title":"J. Med. Case Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4269\/ajtmh.16-0434","article-title":"The Jarisch-Herxheimer Reaction After Antibiotic Treatment of Spirochetal Infections: A Review of Recent Cases and Our Understanding of Pathogenesis","volume":"96","author":"Butler","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_51","unstructured":"Horowitz, R.I. (2003, January 7\u20138). Effects of Shifting the Acid-Base Balance Among Lyme Patients during Jarish Herxheimer Flares: A Small Prospective Study. Proceedings of the 16th International Scientific Conference on Lyme Disease & Other Tick-Borne Disorders, Hartford, CT, USA."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-Acetylcysteine\u2014a Safe Antidote for Cysteine\/Glutathione Deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.bbagen.2009.07.026","article-title":"Alpha-Lipoic Acid as a Dietary Supplement: Molecular Mechanisms and Therapeutic Potential","volume":"1790","author":"Shay","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fphar.2014.00196","article-title":"Glutathione: New Roles in Redox Signaling for an Old Antioxidant","volume":"5","author":"Aquilano","year":"2014","journal-title":"Front. Pharmacol."},{"key":"ref_55","first-page":"1225","article-title":"N-Acetyl Cysteine Blocks Mesangial VCAM-1 and NF-Kappa B Expression in Vivo","volume":"151","author":"Khachigian","year":"1997","journal-title":"Am. J. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/toxsci\/kfq098","article-title":"The Glutaredoxin\/Glutathione System Modulates NF-KappaB Activity by Glutathionylation of P65 in Cinnamaldehyde-Treated Endothelial Cells","volume":"116","author":"Liao","year":"2010","journal-title":"Toxicol. Sci. Off. J. Soc. Toxicol."},{"key":"ref_57","unstructured":"Stokes, M., and Abdijadid, S. (2020). Disulfiram. StatPearls, StatPearls Publishing."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2147\/DDDT.S101486","article-title":"Identification of New Drug Candidates against Borrelia burgdorferi Using High-Throughput Screening","volume":"10","author":"Pothineni","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ja.2016.131","article-title":"Screening of NCI-DTP Library to Identify New Drug Candidates for Borrelia burgdorferi","volume":"70","author":"Pothineni","year":"2017","journal-title":"J. Antibiot."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/jam.12970","article-title":"In Vitro Evaluation of Antibacterial Activity of Phytochemicals and Micronutrients against Borrelia burgdorferi and Borrelia garinii","volume":"119","author":"Goc","year":"2015","journal-title":"J. Appl. Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e00544","DOI":"10.1016\/j.btre.2020.e00544","article-title":"Serratiopeptidase: Insights into the Therapeutic Applications","volume":"28","author":"Jadhav","year":"2020","journal-title":"Biotechnol. Rep."},{"key":"ref_62","first-page":"75","article-title":"The Anti-Borreliae Efficacy of Phytochemicals and Micronutrients: An Update","volume":"3","author":"Goc","year":"2016","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_63","first-page":"25","article-title":"An in Vitro Study of the Susceptibility of Mobile and Cystic Forms of Borrelia burgdorferi to Hydroxychloroquine","volume":"5","author":"Brorson","year":"2002","journal-title":"Int. Microbiol. Off. J. Span. Soc. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ewjm.175.3.193","article-title":"Methemoglobinemia","volume":"175","author":"Rehman","year":"2001","journal-title":"West. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Aucott, J., Morrison, C., Munoz, B., Rowe, P.C., Schwarzwalder, A., and West, S.K. (2009). Diagnostic Challenges of Early Lyme Disease: Lessons from a Community Case Series. BMC Infect. Dis., 9.","DOI":"10.1186\/1471-2334-9-79"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Johnson, L., Shapiro, M., and Mankoff, J. (2018). Removing the Mask of Average Treatment Effects in Chronic Lyme Disease Research Using Big Data and Subgroup Analysis. Healthcare, 6.","DOI":"10.3390\/healthcare6040124"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e021367","DOI":"10.1136\/bmjopen-2017-021367","article-title":"Obstacles to Diagnosis and Treatment of Lyme Disease in the USA: A Qualitative Study","volume":"8","author":"Hirsch","year":"2018","journal-title":"BMJ Open"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","article-title":"Duration of Antibiotic Therapy for Early Lyme Disease. A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"138","author":"Wormser","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"100142","DOI":"10.1016\/j.lanepe.2021.100142","article-title":"Prevalence of Persistent Symptoms after Treatment for Lyme Borreliosis: A Prospective Observational Cohort Study","volume":"6","author":"Ursinus","year":"2021","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11136-012-0126-6","article-title":"Post-Treatment Lyme Disease Syndrome Symptomatology and the Impact on Life Functioning: Is There Something Here?","volume":"22","author":"Aucott","year":"2013","journal-title":"Qual. Life Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13690-017-0202-z","article-title":"The HUMTICK Study: Protocol for a Prospective Cohort Study on Post-Treatment Lyme Disease Syndrome and the Disease and Cost Burden of Lyme Borreliosis in Belgium","volume":"75","author":"Geebelen","year":"2017","journal-title":"Arch. Public Health Arch. Belg. Sante Publique"},{"key":"ref_72","first-page":"e443","article-title":"Development of a Foundation for a Case Definition of Post-Treatment Lyme Disease Syndrome","volume":"17","author":"Aucott","year":"2013","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.31744\/einstein_journal\/2021RC6369","article-title":"Long Term Persistence of Coronavirus SARS-CoV-2 Infection","volume":"19","author":"Pinho","year":"2021","journal-title":"einstein"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological Sequelae of Long-Haul COVID","volume":"23","author":"Mehandru","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Gold, J.E., Okyay, R.A., Licht, W.E., and Hurley, D.J. (2021). Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens, 10.","DOI":"10.3390\/pathogens10060763"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1080\/10715762.2021.2005247","article-title":"SARS-CoV-2 Induces Mitochondrial Dysfunction and Cell Death by Oxidative Stress\/Inflammation in Leukocytes of COVID-19 Patients","volume":"55","year":"2021","journal-title":"Free Radic. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10286-021-00798-2","article-title":"Long-COVID Postural Tachycardia Syndrome: An American Autonomic Society Statement","volume":"31","author":"Raj","year":"2021","journal-title":"Clin. Auton. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.dsx.2021.04.007","article-title":"Long COVID: An Overview","volume":"15","author":"Raveendran","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact","volume":"38","author":"Davis","year":"2021","journal-title":"eClinicalMedicine"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Siracusa, R., Paola, R.D., Cuzzocrea, S., and Impellizzeri, D. (2021). Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22083891"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fmed.2020.00057","article-title":"Post-Treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease","volume":"7","author":"Rebman","year":"2020","journal-title":"Front. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/cid\/ciab611","article-title":"Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study","volume":"74","author":"Waterboer","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Citera, M., Freeman, P.R., and Horowitz, R.I. (2018, July 11). Empirical Validation of the Horowitz Multiple Systemic Infectious Disease Syndrome Questionnaire for Suspected Lyme Disease. Available online: https:\/\/www.dovepress.com\/empirical-validation-of-the-horowitz-multiple-systemic-infectious-dise-peer-reviewed-article-IJGM.","DOI":"10.2147\/IJGM.S140224"},{"key":"ref_84","unstructured":"(2022, April 24). UCI Proposed RCT on Glutathione Deficiency and MSIDS Abnormalities in COVID Longhaulers\u2014You Can Get Better. Available online: https:\/\/cangetbetter.com\/uci-proposed-rct-on-glutathione-deficiency-and-msids-abnormalities-in-covid-longhaulers\/."},{"key":"ref_85","first-page":"958","article-title":"Dapsone-Induced Methemoglobinemia","volume":"59","author":"Burke","year":"2013","journal-title":"Can. Fam. Physician"},{"key":"ref_86","unstructured":"Soghoian, S. (2022, July 05). Disulfiram Toxicity: Practice Essentials, Pathophysiology, Etiology. Available online: https:\/\/emedicine.medscape.com\/article\/814525-overview."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bcp.2009.08.025","article-title":"N-Acetyl-L-Cysteine (NAC) Inhibits Virus Replication and Expression of pro-Inflammatory Molecules in A549 Cells Infected with Highly Pathogenic H5N1 Influenza A Virus","volume":"79","author":"Geiler","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/0006-291X(92)90275-P","article-title":"Alpha-Lipoic Acid Is a Potent Inhibitor of NF-Kappa B Activation in Human T Cells","volume":"189","author":"Suzuki","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/antibiotics4030397","article-title":"Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library","volume":"4","author":"Feng","year":"2015","journal-title":"Antibiotics"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Zheng, X., Ma, X., Li, T., Shi, W., and Zhang, Y. (2020). Effect of Different Drugs and Drug Combinations on Killing Stationary Phase and Biofilms Recovered Cells of Bartonella henselae in Vitro. BMC Microbiol., 20.","DOI":"10.1186\/s12866-020-01777-9"},{"key":"ref_91","unstructured":"Abouelezz, K.F. (2022, July 05). Methemoglobinemia: Practice Essentials, Background, Pathophysiology. Available online: https:\/\/emedicine.medscape.com\/article\/204178-overview."},{"key":"ref_92","first-page":"97","article-title":"Antioxidant Effect of Different Vitamins on Methemoglobin Production: An in Vitro Study","volume":"3","author":"Atyabi","year":"2012","journal-title":"Vet. Res. Forum."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2133.1995.tb05022.x","article-title":"Cimetidine Improves the Therapeutic\/Toxic Ratio of Dapsone in Patients on Chronic Dapsone Therapy","volume":"132","author":"Rhodes","year":"1995","journal-title":"Br. J. Dermatol."},{"key":"ref_94","unstructured":"Bistas, E., and Sanghavi, D. (2022). Methylene Blue. StatPearls, StatPearls Publishing."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/picr.PICR_55_18","article-title":"Are Drug-Drug Interactions a Real Clinical Concern?","volume":"10","author":"Das","year":"2019","journal-title":"Perspect. Clin. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/2279-042X.192461","article-title":"A Comparison of Five Common Drug\u2013Drug Interaction Software Programs Regarding Accuracy and Comprehensiveness","volume":"5","author":"Kheshti","year":"2016","journal-title":"J. Res. Pharm. Pract."},{"key":"ref_97","unstructured":"(2022, April 26). Dietary Restrictions & Drug Interactions with MAOI | Psychiatrist.Com. Available online: https:\/\/www.psychiatrist.com\/jcp\/depression\/dietary-restrictions-drug-interactions-monoamine-oxidase-update-maoi\/."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1537-2995.2000.40030375.x","article-title":"Fulminant Babesiosis Treated with Clindamycin, Quinine, and Whole-Blood Exchange Transfusion","volume":"40","author":"Dorman","year":"2000","journal-title":"Transfusion"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1056\/NEJM200011163432004","article-title":"Atovaquone and Azithromycin for the Treatment of Babesiosis","volume":"343","author":"Krause","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_100","first-page":"49","article-title":"Human Babesiosis and Ehrlichiosis\u2014Current Status","volume":"6","author":"Shah","year":"2012","journal-title":"Eur. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1086\/523731","article-title":"Treatment of Refractory Babesia Microti Infection with Atovaquone-Proguanil in an HIV-Infected Patient: Case Report","volume":"45","author":"Vyas","year":"2007","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e01460","DOI":"10.1016\/j.idcr.2022.e01460","article-title":"Use of Tafenoquine to Treat a Patient with Relapsing Babesiosis with Clinical and Molecular Evidence of Resistance to Azithromycin and Atovaquone","volume":"27","author":"Marcos","year":"2022","journal-title":"IDCases"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Renard, I., and Ben Mamoun, C. (2021). Treatment of Human Babesiosis: Then and Now. Pathogens, 10.","DOI":"10.3390\/pathogens10091120"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"624745","DOI":"10.3389\/fcimb.2021.624745","article-title":"Botanical Medicines Cryptolepis Sanguinolenta, Artemisia Annua, Scutellaria Baicalensis, Polygonum Cuspidatum, and Alchornea Cordifolia Demonstrate Inhibitory Activity Against Babesia Duncani","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_105","unstructured":"Horowitz, R.I. (, January April). Chronic Persistent Babesiosis after Clindamycin and Quinine\/Mepron and Zithromax. Proceedings of the 12th International Conference on Lyme Borreliosis, New York, NY, USA. [Abstract]."},{"key":"ref_106","unstructured":"Office of HIV\/AIDS and Infectious Disease Policy, Assistant Secretary for Health (2018, May 21). (ASH) Report of Other TBDS and Co-Infections Subcommittee, Available online: https:\/\/www.hhs.gov\/ash\/advisory-committees\/tickbornedisease\/reports\/other-tbds-2018-5-9\/index.html."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"16079","DOI":"10.1038\/nmicrobiol.2016.79","article-title":"A Global Map of Genetic Diversity in Babesia Microti Reveals Strong Population Structure and Identifies Variants Associated with Clinical Relapse","volume":"1","author":"Lemieux","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/cid\/cix477","article-title":"Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia Microti Infection Associated With Rituximab and Chronic Lymphocytic Leukemia","volume":"65","author":"Simon","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.7717\/peerj.322","article-title":"Severity of Chronic Lyme Disease Compared to Other Chronic Conditions: A Quality of Life Survey","volume":"2","author":"Johnson","year":"2014","journal-title":"PeerJ"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Shah, J.S., Mark, O., Caoili, E., Poruri, A., Horowitz, R.I., Ashbaugh, A.D., and Ramasamy, R. (2020). A Fluorescence in Situ Hybridization (FISH) Test for Diagnosing Babesiosis. Diagnostics, 10.","DOI":"10.3390\/diagnostics10060377"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/femsre\/fuy040","article-title":"Fluorescence in Situ Hybridization, a Complementary Molecular Tool for the Clinical Diagnosis of Infectious Diseases by Intracellular and Fastidious Bacteria","volume":"43","author":"Prudent","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/CCID.S184521","article-title":"Detection of Tick-Borne Infection in Morgellons Disease Patients by Serological and Molecular Techniques","volume":"11","author":"Middelveen","year":"2018","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Krislee, A., Fadly, C., Nugrahaningsih, D.A.A., Nuryastuti, T., Nitbani, F.O., and Sholikhah, E.N. (2019). The 1-Monolaurin Inhibit Growth and Eradicate the Biofilm Formed by Clinical Isolates of Staphylococcus epidermidis. BMC Proc., 13.","DOI":"10.1186\/s12919-019-0174-9"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fmicb.2015.00420","article-title":"Sub-MICs of Mentha Piperita Essential Oil and Menthol Inhibits AHL Mediated Quorum Sensing and Biofilm of Gram-Negative Bacteria","volume":"6","author":"Husain","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Ma, X., Shi, W., and Zhang, Y. (2019). Essential Oils with High Activity Against Stationary Phase Bartonella henselae. Antibiotics, 8.","DOI":"10.20944\/preprints201910.0178.v1"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1128\/AAC.00864-15","article-title":"Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells","volume":"59","author":"Sharma","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1128\/AAC.00883-15","article-title":"Persister Development by Borrelia burgdorferi Populations In Vitro","volume":"59","author":"Caskey","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3389\/fmicb.2016.00743","article-title":"A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library","volume":"7","author":"Feng","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_119","first-page":"12","article-title":"Are Mycobacterium Drugs Effective for Treatment Resistant Lyme Disease, Tick-Borne Co-Infections, and Autoimmune Disease?","volume":"1","author":"Horowitz","year":"2016","journal-title":"JSM Arthritis"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Li, T., Feng, J., Xiao, S., Shi, W., Sullivan, D., and Zhang, Y. (2019). Identification of FDA-Approved Drugs with Activity against Stationary Phase Bartonella henselae. Antibiotics, 8.","DOI":"10.3390\/antibiotics8020050"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJM199807163390304","article-title":"Persistent Parasitemia after Acute Babesiosis","volume":"339","author":"Krause","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/14787210.2020.1752193","article-title":"Management Strategies for Human Babesiosis","volume":"18","author":"Smith","year":"2020","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrd1008","article-title":"Understanding Biofilm Resistance to Antibacterial Agents","volume":"2","author":"Davies","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Pandey, R.P., Mukherjee, R., and Chang, C.-M. (2022). Emerging Concern with Imminent Therapeutic Strategies for Treating Resistance in Biofilm. Antibiotics, 11.","DOI":"10.3390\/antibiotics11040476"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and Evolution of Antibiotic Resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1099\/mic.0.000027","article-title":"Morphological and Biochemical Features of Borrelia burgdorferi Pleomorphic Forms","volume":"161","author":"Herranen","year":"2015","journal-title":"Microbiology"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1128\/IAI.71.4.1689-1705.2003","article-title":"Profiling of Temperature-Induced Changes in Borrelia burgdorferi Gene Expression by Using Whole Genome Arrays","volume":"71","author":"Ojaimi","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF01713153","article-title":"Transformation of Cystic Forms of Borrelia burgdorferi to Normal, Mobile Spirochetes","volume":"25","author":"Brorson","year":"1997","journal-title":"Infection"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0463.2004.apm1120110.x","article-title":"Induction of Cystic Forms by Different Stress Conditions in Borrelia burgdorferi","volume":"112","author":"Murgia","year":"2004","journal-title":"APMIS"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1556\/1886.2015.00049","article-title":"Evidence of In Vivo Existence of Borrelia Biofilm in Borrelial Lymphocytomas","volume":"6","author":"Sapi","year":"2016","journal-title":"Eur. J. Microbiol. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13071-019-3495-7","article-title":"Metamorphoses of Lyme Disease Spirochetes: Phenomenon of Borrelia Persisters","volume":"12","author":"Rudenko","year":"2019","journal-title":"Parasit. Vectors"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1038\/emi.2014.3","article-title":"Persisters, Persistent Infections and the Yin\u2013Yang Model","volume":"3","author":"Zhang","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrmicro1557","article-title":"Persister Cells, Dormancy and Infectious Disease","volume":"5","author":"Lewis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial Biofilms: A Common Cause of Persistent Infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"7116","DOI":"10.1128\/AEM.02636-13","article-title":"Bacterial Persister Cell Formation and Dormancy","volume":"79","author":"Wood","year":"2013","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1038\/emi.2014.53","article-title":"Identification of Novel Activity against Borrelia burgdorferi Persisters Using an FDA Approved Drug Library","volume":"3","author":"Feng","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fneur.2018.01048","article-title":"The Emerging Role of Microbial Biofilm in Lyme Neuroborreliosis","volume":"9","author":"Cavallo","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and Treatment of Post Lyme Disease (STOP-LD): A Randomized Double Masked Clinical Trial","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","article-title":"A Randomized, Placebo-Controlled Trial of Repeated IV Antibiotic Therapy for Lyme Encephalopathy","volume":"70","author":"Fallon","year":"2008","journal-title":"Neurology"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/toxins5040605","article-title":"Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome","volume":"5","author":"Brewer","year":"2013","journal-title":"Toxins"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Bossou, Y.M., Serssar, Y., Allou, A., Vitry, S., Momas, I., Seta, N., Menotti, J., and Achard, S. (2017). Impact of Mycotoxins Secreted by Aspergillus Molds on the Inflammatory Response of Human Corneal Epithelial Cells. Toxins, 9.","DOI":"10.3390\/toxins9070197"},{"key":"ref_143","first-page":"84","article-title":"The Postural Tachycardia Syndrome (POTS): Pathophysiology, Diagnosis & Management","volume":"6","author":"Raj","year":"2006","journal-title":"Indian Pacing Electrophysiol. J."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/10408440600845619","article-title":"The Toxicology of Mercury and Its Chemical Compounds","volume":"36","author":"Clarkson","year":"2006","journal-title":"Crit. Rev. Toxicol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7326\/0003-4819-159-1-201307020-00009","article-title":"Borrelia miyamotoi: A Lesson in Disease Discovery","volume":"159","author":"Branda","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"101540","DOI":"10.1016\/j.ttbdis.2020.101540","article-title":"The Emergence of Human Powassan Virus Infection in North America","volume":"11","author":"Campbell","year":"2020","journal-title":"Ticks Tick-Borne Dis."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Reis, C., Cote, M., Le Rhun, D., Lecuelle, B., Levin, M.L., Vayssier-Taussat, M., and Bonnet, S.I. (2011). Vector competence of the tick Ixodes ricinus for transmission of Bartonella birtlesii. PLoS Negl. Trop. Dis., 5.","DOI":"10.1371\/journal.pntd.0001186"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/9781119278368.ch5.2","article-title":"Bartonellosis, One Health and all creatures great and small","volume":"28","author":"Breitschwerdt","year":"2017","journal-title":"Vet. Dermatol."},{"key":"ref_149","first-page":"29","article-title":"Potential Effects of Climate Change on Tick-Borne Diseases in Rhode Island","volume":"104","author":"Ginsberg","year":"2021","journal-title":"Rhode Isl. Med. J."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"593232","DOI":"10.1155\/2009\/593232","article-title":"Effects of Climate Change on Ticks and Tick-Borne Diseases in Europe","volume":"2009","author":"Gray","year":"2009","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/eurpub\/ckw269","article-title":"The Cost of Lyme Borreliosis","volume":"27","author":"Hofhuis","year":"2017","journal-title":"Eur. J. Public Health"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1038\/s41598-020-59600-4","article-title":"Azlocillin Can Be the Potential Drug Candidate against Drug-Tolerant Borrelia burgdorferi Sensu Stricto JLB31","volume":"10","author":"Pothineni","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.chom.2021.10.007","article-title":"Hygromycin A in the Lymelight","volume":"29","author":"Arnaboldi","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref_154","unstructured":"(2022, April 26). Understanding Lyme and Other Tickborne Diseases | Division of Vector-Borne Diseases | NCEZID | CDC, Available online: https:\/\/www.cdc.gov\/ncezid\/dvbd\/media\/lyme-tickborne-diseases-increasing.html."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e007744","DOI":"10.1136\/bmjgh-2021-007744","article-title":"Global seroprevalence and sociodemographic characteristics of Borrelia burgdorferi sensu lato in human populations: A systematic review and meta-analysis","volume":"7","author":"Dong","year":"2022","journal-title":"BMJ Glob. Health"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/7\/912\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:43:49Z","timestamp":1760139829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/7\/912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":155,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["antibiotics11070912"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics11070912","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202204.0296.v1","asserted-by":"object"}]},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]}}}